GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor
Non-Small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Pancreatic Ductal Adenocarcinoma (PDAC)

Interventions

BIOLOGICAL: GEN1042
DRUG: Pembrolizumab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: 5-FU
DRUG: Gemcitabine
DRUG: Nab paclitaxel
DRUG: Pemetrexed
DRUG: Paclitaxel

Sponsor

Genmab

Collaborators

[object Object]